Recent research in preclinical mouse models has unveiled promising findings about the combined effects of cannabidiol (CBD) and metformin in addressing behavioural challenges.
The global industrial hemp market is on a rapid growth trajectory, with projections indicating a compound annual growth rate (CAGR) of 20.1% over the next several years.
Botswana, a nation long reliant on diamond mining as the backbone of its economy, is exploring new horizons. President Mokgweetsi Masisi has signaled a strategic shift toward cultivating hemp and medical cannabis as a means of reducing the country’s dependency on diamonds.
In a landmark move, Moldova has officially legalized the cultivation of hemp for seed and fiber production, opening the door for economic opportunities in agriculture and industry.
Since hemp was re-legalized for cultivation in the United States in 2018, the plant has been riding a wave of excitement. The CBD craze may have stolen the spotlight, but hemp is proving itself to be much more than just a wellness trend.
The European Union is ready to supply medical cannabis to the nation, according to Ukraine’s Deputy Health Minister Maryna Slobodnichenko. In a recent interview with the Ukrainian News Agency, she revealed that the EU is eager to support Ukraine’s medical cannabis program, which officially launched in August 2024.
Reforms to hemp licensing regulations are on the way, aiming to make it easier for regulated farmers to grow the versatile crop and unlock its economic potential.
CBD (cannabidiol) comes in different types, each with distinct characteristics. The most common types are Full Spectrum, CBD Isolate, and Broad Spectrum. Here’s a simple guide to help you understand their differences. 1. Full Spectrum CBD What is it? Full Spectrum CBD contains all the naturally occurring compounds found in the cannabis plant, including cannabinoids, …
Full Spectrum, Isolate, and Broad Spectrum – a simple guide to CBD types Read More »
A new study published in Clinical Pharmacology & Therapeutics has turned the common cannabis wisdom on its head, proving once again that science loves to mess with everything we think we know.
The European Commission has launched an investigation into Italy’s recent attempts to restrict the sale and use of cannabidiol (CBD) products, following concerns that these measures may violate European Union laws on the free movement of goods.
